International Stem Cell Corporation (OTCBB:ISCO) (www.internationalstemcell.com),
a California-based stem cell therapeutics company, today announced that
the Company has been invited to present at the 20th
Annual Roth Capital Partners Orange County Growth Stock Conference to be
held at The Ritz Carlton Laguna Niguel,located at One
Ritz-Carlton Drive, Dana Point, California 92629.
ISCO is scheduled to present on Tuesday, February 19, 2008 at 2:00 P.M.,
Pacific Time. Chairman and Chief Executive Officer Kenneth Aldrich will
represent the company.
The Roth Conference, the largest of its kind in the nation, is expected
to attract over 1000 institutional investors or buyside attendees.
Interested parties can access a live audio web cast of this presentation
at: http://www.wsw.com/webcast/roth16/stemcell/.
A replay of this presentation will be available at the same location.
ABOUT INTERNATIONAL STEM CELL CORPORATION:
International Stem Cell Corporation (ISCO) is a California biotechnology
company focused on developing therapeutic and research products. ISCO's
technology, Parthenogenesis, results in the creation of
pluripotent human stem cell lines from unfertilized human eggs. ISCO
scientists also have created the first Parthenogenic homozygous stem
cell line (phSC-Hhom-4) that can be a source of therapeutic cells
that will not be immune rejected after transplantation into millions of
individuals of differing sexes, ages and racial groups. These
advancements offer the potential to create the first true "Stem
Cell Bank" and address ethical issues by
eliminating the need to use or destroy fertilized embryos. ISCO also
produces and markets specialized cells and growth media worldwide for
therapeutic research through its subsidiary Lifeline Cell Technology.
For more information, visit the ISCO website at: www.internationalstemcell.com.
To subscribe to receive ongoing corporate communications please click on
the following link: http://www.b2i.us/irpass.asp?BzID=1468&to=ea&s=0.
About Roth Capital OC Conference
ROTH Conferences are one of the largest in the nation for micro and
small cap companies. Now in its 20th year, the ROTH Annual OC Conference
will feature presentations from over 300 small-cap companies. The
distinguished list of presenting companies have been identified by ROTH's
award-winning research team and are representative of a broad spectrum
of sectors, including Technology, Healthcare, Energy and Industrial as
well as Consumer Products. The conference will be held February 18-21st,
2008.
Forward-Looking Statements Statements pertaining to future financial and/or operating results,
future growth in research, technology, clinical development and
potential opportunities for the company and its subsidiary, along with
other statements about the future expectations, beliefs, goals, plans,
or prospects expressed by management constitute forward-looking
statements. Any statements that are not historical fact (including, but
not limited to statements that contain words such as "will,""believes,""plans,""anticipates,""expects,""estimates,")
should also be considered to be forward-looking statements.
Forward-looking statements involve risks and uncertainties, including,
without limitation, risks inherent in the development and/or
commercialization of potential products, uncertainty in the results of
clinical trials or regulatory approvals, need and ability to obtain
future capital, and maintenance of intellectual property rights. Actual
results may differ materially from the results anticipated in these
forward-looking statements and as such should be evaluated together with
the many uncertainties that affect the company's business, particularly
those mentioned in the cautionary statements found in the company's
Securities and Exchange Commission filings. The company disclaims any
intent or obligation to update these forward-looking statements. |
